Dr. Russell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of Edinburg Medical SchoolClass of 1982
Certifications & Licensure
MN State Medical License 2003 - 2025
Publications & Presentations
PubMed
- 1 citationsSurface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and histori...Miguel Á Muñoz-Alía, Rebecca A Nace, Baskar Balakrishnan, Lianwen Zhang, Nandakumar Packiriswamy
Mbio. 2024-02-14 - 2 citationsPolycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model.Velia Penza, Justin W Maroun, Rebecca A Nace, Autumn J Schulze, Stephen J Russell
Molecular Therapy Oncolytics. 2023-03-16 - 1 citationsSurface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody r...Miguel Á Muñoz-Alía, Rebecca A Nace, Baskar Balakrishnan, Lianwen Zhang, Nandakumar Packiriswamy
Biorxiv. 2022-12-16
Journal Articles
- Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple MyelomaS Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
- Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy: Failure of the Serum Free Light Chain RatioMorie A Gertz, David Dingli, Miriam Hobbs, John A Lust, Ronald S Go, Amie Fonder, Yi Lin, Shaji K Kumar, Prashant Kapoor, Taxiarchis V Kourelis, S Vincent Rajkumar, Ro..., Nature
- Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature
Abstracts/Posters
- Development of a Sensitive and Efficient Reporter Platform for the Detection of Chimeric Antigen Receptor T Cell Expansion, Trafficking, and ToxicityStephen J Russell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at DiagnosisStephen J Russell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple MyelomaStephen J Russell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Children with Mild Covid-19 May Not Develop Antibodies; Oral Vaccine Booster Shows Promise in Monkey StudyOctober 20th, 2021- How Viruses Could Cure Cancer and Save LivesJune 29th, 2021
- Will We Need a COVID-19 Vaccine Booster Shot Later This Year?May 30th, 2021
- Join now to see all
Grant Support
- Antibody Neutralization Of Therapeutic VirusesNational Cancer Institute2008–2012
- Radiovirotherapy For Multiple MyelomaNational Cancer Institute2004–2012
- Virotherapy For Squamous Cell Carcinoma Of The Head And NeckNational Cancer Institute2010
- Monitoring Expression Of Cell Associated Transgenes /Vector CoreNational Heart, Lung, And Blood Institute2005
- Gene Therapy For Vaso-Occlusive DisordersNational Heart, Lung, And Blood Institute2004–2005
- Radiovirotherapy For Multiple MyelomaNational Cancer Institute2003
- Gene Therapy For Vaso-Occlusive DisordersNational Heart, Lung, And Blood Institute2001–2003
- Monitoring Expression Of Cell Associated Transgenes /Vector CoreNational Heart, Lung, And Blood Institute2001–2002
- Targeting Angiogenesis With Protease Activatable VectorsNational Cancer Institute1999–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
